Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multicenter pilot study, proposed for cases and controls 3 departments in France.

Cases are cured patients who have had prostate cancer for at least 10 years. Cookies are healthy subjects selected by lottery on voter list.

Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program

NCT01786031

Metastatic Castration Resistant Prostate Cancer Patients

COMPLETED NA

Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer

NCT02876237

Prostate Cancer

COMPLETED NA

STUDY OF PREFERENCES IN MEN FACED WITH THE DIFFERENT TREATMENT OPTIONS FOR LOCALIZED PROSTRATE CANCER WITH A GOOD OR INTERMEDIATE PROGNOSIS

NCT02080793

Patients Seen at a Urology Consultation

COMPLETED NA

Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory Study

NCT05612204

Prostate Cancer

RECRUITING NA

Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney

NCT06214000

Prostate Cancer Kidney Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician.

During this consultation, ADL, IADL and MMS questionnary will be completed. neurocognitif testing will be done.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer Cured Healthy Population Control

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

geriatric assessment

Group Type OTHER

geriatric assessment

Intervention Type OTHER

A single geriatric assessment with a geriatrician was proposed to patients and to control population.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

geriatric assessment

A single geriatric assessment with a geriatrician was proposed to patients and to control population.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 75 years or more
* Patients with a personal history of prostate cancer with a diagnosis ≥ 10 years
* Patients who received curative treatment (surgery, radiotherapy,hormone therapy, brachytherapy, technical ablative) for localized prostate cancer
* Patients considered cured of prostate cancer (regardless of initial treatment)
* Patients with previously agreed to participate in a case-control study in the general population (study QALIPRO) as a case and volunteer to receive an assessment of geriatric
* Signature of consent
* Affiliation to a social security system

* Male subjects
* Subjects of 75 years or more
* Subjects that do not have cancer or a history of cancer (except basal cell skin cancer)
* Subject has previously agreed to participate in a case-control study in the general population (study QALIPRO) as a voluntary witness and to benefit from a balance oncogeriatrics
* Subjects who gave their written consent to participate in the study